Jefferies Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $17M | Buy |
75,480
+73,479
| +3,672% | +$17.8M | 0.14% | 112 |
|
|
2022
Q2 | $487K | Buy |
+2,001
| New | +$490K | ﹤0.01% | 1010 |
|
|
2022
Q1 | – | Sell |
-173,899
| Closed | -$39.1M | – | 1512 |
|
|
2021
Q4 | $39.1M | Sell |
173,899
-44,335
| -20% | -$9.36M | 0.23% | 64 |
|
|
2021
Q3 | $46.4M | Buy |
218,234
+19,021
| +10% | +$4.38M | 0.34% | 41 |
|
|
2021
Q2 | $48.6M | Buy |
199,213
+160,199
| +411% | +$39.4M | 0.31% | 49 |
|
|
2021
Q1 | $9.71M | Sell |
39,014
-71,966
| -65% | -$17.2M | 0.09% | 204 |
|
|
2020
Q4 | $25.5M | Buy |
110,980
+104,970
| +1,747% | +$24.2M | 0.2% | 74 |
|
|
2020
Q3 | $1.53M | Sell |
6,010
-12,445
| -67% | -$3.08M | 0.02% | 666 |
|
|
2020
Q2 | $4.35K | Sell |
18,455
-21,445
| -54% | -$4.89M | 0.05% | 307 |
|
|
2020
Q1 | $8.32M | Buy |
39,900
+25,800
| +183% | +$5.64M | 0.09% | 190 |
|
|
2019
Q4 | $3.4M | Sell |
14,100
-17,255
| -55% | -$3.8M | 0.03% | 737 |
|
|
2019
Q3 | $6.07M | Sell |
31,355
-50,145
| -62% | -$9.63M | 0.05% | 417 |
|
|
2019
Q2 | $15M | Buy |
81,500
+80,350
| +6,987% | +$14.4M | 0.11% | 136 |
|
|
2019
Q1 | $218K | Sell |
1,150
-9,988
| -90% | -$1.91M | ﹤0.01% | 1916 |
|
|
2018
Q4 | $2.17M | Buy |
11,138
+4,775
| +75% | +$932K | 0.02% | 776 |
|
|
2018
Q3 | $1.32M | Sell |
6,363
-102
| -2% | -$20.1K | 0.01% | 1186 |
|
|
2018
Q2 | $1.19M | Sell |
6,465
-69,262
| -91% | -$12.3M | 0.01% | 1162 |
|
|
2018
Q1 | $12.9M | Buy |
75,727
+26,819
| +55% | +$4.92M | 0.07% | 189 |
|
|
2017
Q4 | $8.51M | Buy |
48,908
+7,468
| +18% | +$1.32M | 0.04% | 354 |
|
|
2017
Q3 | $7.73M | Buy |
41,440
+36,004
| +662% | +$6.38M | 0.05% | 372 |
|
|
2017
Q2 | $936K | Sell |
5,436
-69,712
| -93% | -$11.3M | 0.01% | 1343 |
|
|
2017
Q1 | $12.3M | Buy |
75,148
+74,322
| +8,998% | +$12.3M | 0.09% | 207 |
|
|
2016
Q4 | $121K | Sell |
826
-40,864
| -98% | -$6.15M | ﹤0.01% | 1995 |
|
|
2016
Q3 | $6.95M | Sell |
41,690
-11,035
| -21% | -$1.87M | 0.04% | 424 |
|
|
2016
Q2 | $8.02M | Buy |
52,725
+48,723
| +1,217% | +$7.58M | 0.04% | 344 |
|
|
2016
Q1 | $600K | Sell |
4,002
-1,937
| -33% | -$288K | ﹤0.01% | 1373 |
|
|
2015
Q4 | $964K | Sell |
5,939
-68,541
| -92% | -$10.8M | 0.01% | 1192 |
|
|
2015
Q3 | $10.3M | Buy |
74,480
+69,223
| +1,317% | +$10.9M | 0.06% | 257 |
|
|
2015
Q2 | $807K | Sell |
5,257
-49,943
| -90% | -$8M | ﹤0.01% | 1345 |
|
|
2015
Q1 | $8.82M | Buy |
55,200
+23,698
| +75% | +$3.73M | 0.05% | 271 |
|
|
2014
Q4 | $5.02M | Sell |
31,502
-81,419
| -72% | -$12.7M | 0.03% | 423 |
|
|
2014
Q3 | $15.9M | Sell |
112,921
-1,759
| -2% | -$230K | 0.11% | 165 |
|
|
2014
Q2 | $13.6M | Buy |
114,680
+96,879
| +544% | +$11.2M | 0.11% | 160 |
|
|
2014
Q1 | $2.2M | Buy |
17,801
+1,907
| +12% | +$231K | 0.02% | 577 |
|
|
2013
Q4 | $1.81M | Buy |
15,894
+6,007
| +61% | +$683K | 0.01% | 610 |
|
|
2013
Q3 | $1.11M | Buy |
9,887
+2,486
| +34% | +$270K | 0.01% | 864 |
|
|
2013
Q2 | $730K | Buy |
+7,401
| New | +$768K | 0.01% | 902 |
|
Other funds holding AMGN
Jefferies Group's AMGN Position: Q3 2022 in Review
Jefferies Group increased its Amgen (AMGN) stake by 3,672% in Q3 2022, buying an estimated $17.8M and bringing the position to 75,480 shares worth $17M. The position accounts for 0.14% of the portfolio, ranked #112.
Jefferies Group first reported a position in AMGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $48.6M in Q2 2021. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- Jefferies Group held 75,480 shares of Amgen worth $17M as of Q3 2022.
- Jefferies Group bought 73,479 Amgen shares in Q3 2022, an estimated $17.8M.
- Amgen made up 0.14% of Jefferies Group's portfolio in Q3 2022, its #112 holding.
- Jefferies Group first reported a position in Amgen in Q2 2013 and has held it in 37 quarters since.
- Jefferies Group's Amgen position peaked at $48.6M in Q2 2021.
- 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.